bispecific antibodies for t‐cell redirection therapy
Published 7 years ago • 9K plays • Length 21:32Download video MP4
Download video MP3
Similar videos
-
3:00
drawn to science | t-cell bispecific antibodies
-
2:11
bispecific antibodies enable synthetic agonistic receptor t-cell therapy in melanoma
-
1:14
the car t-cell strategy vs bispecific antibodies
-
8:00
cd3 x cd33 bispecific antibodies redirect donor t-cells against hla loss
-
30:36
bispecific antibodies to engage vγ9vδ2-t cells for cancer immunotherapy
-
14:00
what are bispecific antibodies?
-
4:35
bispecific antibodies vs car t-cells for r/r multiple myeloma
-
49:07
a mucin 16 bispecific t cell-engaging antibody for the treatment of ovarian cancer
-
4:26
what are bispecific antibodies?
-
12:15
car-t vs bispecific antibodies for lymphoma
-
14:56
updates on the development of self‐assembling bispecific antibodies
-
1:01
bispecific antibodies being used as a t-cell targeting system to wipe out cancer cells
-
3:03
what are the key differences between bispecific antibodies and car t cells?
-
4:55
are there any bispecific antibodies that are fda approved?
-
4:34
antibody-based and bispecific t-cell dependent therapies
-
1:15:12
innovations from the therapeutics antibody space: obligate bispecific antibodies & t cell engagers
-
2:43
bispecific antibodies for non-hodgkin lymphoma
-
1:15
the role of bispecific antibodies in the treatment of r/r large b-cell lymphoma
-
9:00
bispecific t-cell engaging therapy for adult all